Skip to Content

New Drug Approvals Archive - January 2004

January 2004

Acetadote (acetylcysteine) Injection

Date of Approval: January 23, 2004
Company: Cumberland Pharmaceuticals
Treatment for: Acetaminophen Overdose

Acetadote (acetylcysteine) is an injectable treatment to prevent or lessen potential liver damage resulting from acetaminophen overdose.

Read more: Acetadote (acetylcysteine) FDA Approval History

Caduet (amlodipine and atorvastatin) Tablets

Date of Approval: January 30, 2004
Company: Pfizer Inc.
Treatment for: Hypertension, Dyslipidemia, Angina Pectoris

Caduet (amlodipine and atorvastatin) is calcium channel blocker and HMG-CoA reductase inhibitor combination used for the treatment of hypertension, angina and for the prevention of cardiovascular disease.

Read more: Caduet (amlodipine and atorvastatin) FDA Approval History

Spiriva (tiotropium bromide) Inhalation Powder - formerly Spiriva HandiHaler

Date of Approval: January 30, 2004
Company: Boehringer Ingelheim
Treatment for: Chronic Obstructive Pulmonary Disease -- Maintenance

Spiriva HandiHaler (tiotropium bromide) is an anticholinergic indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations.

Read more: Spiriva (tiotropium bromide) FDA Approval History

New Drug Approvals Archive